MedTrace Logo

Predictive Model for Pain After TACE

NCT05545046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 228

Last updated 2022-09-19

No results posted yet for this study

Summary

The main aim of this study was to analyze the risk factors that helped to predict the pain after transarterial chemoembolization (TACE).This was a prospective observational study enrolled all hepatocellular carcinoma (HCC) patients undergoing TACE in our hospital. Pain score at rest was assessed after TACE by the patients themselves using a Visual Analogue Scale (VAS). Independent variables such as age, gender, tumor location, tumor size and number, drug delivery method and presence of portal vein tumor thrombosis (PVTT) were recorded and analyzed.

Conditions

Sponsors & Collaborators

  • Yantai Yuhuangding Hospital

    lead OTHER

Eligibility

Min Age
34 Years
Max Age
87 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05545046 on ClinicalTrials.gov